An observational study in Premature Birth, sponsored by Queen Mary University of London. Recruiting at 2 sites in United Kingdom. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Queen Mary University of London · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 100 studies in Premature Birth with a site in United Kingdom — 19 open to participants now, 25 under way, 1 of them phase 3. Premature Birth · United Kingdom.
Among the 100 studies in Premature Birth with a site in United Kingdom, this one is the 4th largest by planned enrollment of the 46 observational ones that give a count, is one of 3 that started in 2024, is one of 46 observational ones, reaches primary completion later than 24 of the 24 other live ones, and was the 88th registered.
2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.
Browse Premature Birth studies →19 of the 100 studies in Premature Birth with a site in United Kingdom are open now. Recruiting first, the newest first:
King's College Hospital NHS Trust · Sites in United Kingdom
Ages 22 wk–34 wk
Imperial College Healthcare NHS Trust · Sites in United Kingdom
Ages 23 wk–30 wk
Imperial College London · Sites in United Kingdom
Ages up to 30 wk
South Tees Hospitals NHS Foundation Trust · Sites in United Kingdom
Ages 22 wk–32 wk
University of Oxford · Sites in United Kingdom
Ages up to 37 wk
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.
This study: 18 Years and older · female.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
100 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200,000 is above the median of 120 across 809 observational studies indexed under Premature Birth.
Median enrollment 58 across the 54 interventional studies, 150 across the 46 observational. Of the 57 that completed or were terminated, 8 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 100 have an industry lead sponsor. The 10 most frequent:
Queen Mary University of London is the lead sponsor of 253 studies on the registry; 58 are open to participants now.
Queen Mary University of London has 2 studies filed under Premature Birth — fewer than ten, so there is no comparison to draw.
11 of the studies in Premature Birth with a site in United Kingdom that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03168516Phase 3University Hospital TuebingenEffects of Closed-loop Automatic Control of FiO2 in Extremely Preterm Infants | 2026-12 |
| NCT04372953Murdoch Childrens Research InstitutePositive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial). | 2026-11-30 |
| NCT06705257South Tees Hospitals NHS Foundation TrustPEEP FOR LUNG RECRUITMENT IN PRETERM INFANTS-EIT STUDY | 2026-12-31 |
| NCT05306925University of LiverpoolAn Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse | 2026-12-31 |
| NCT06823115Indiana UniversityAssessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | 2027-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 100 studies in Premature Birth with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
We are an inter-disciplinary team of UK scientists with expertise in obstetrics, women's and child health, epidemiology, climate science, inflammation, computational modelling, machine learning and artificial intelligence. Together we have a long history with existing strengths underlying preterm birth research that crosses multiple disciplines and an excellent track record of publications and awards leading research in preterm birth.
We aim to develop and validate a deep learning model to predict the risk of preterm birth and other adverse pregnancy outcomes using data from EPIC electronic health records at University College London Hospital Trust (UCLH) for a cohort of 18000 patients. We will obtain corresponding data on exposure to ambient pollution using non-identifiers for postcode (area) and date of delivery (month). The model will review the temporal sequence of events within a patient's medical history and current pregnancy, identifying significant interactions and will predict the risk of preterm birth. It will also determine the threshold and gestation at which pollution exposure has the greatest impact.
Preterm birth is the leading cause of neonatal morbidity and mortality worldwide. Children born prematurely have higher rates of cerebral palsy, sensory deficits, learning disabilities and respiratory illness. In the UK, approximately 60,000 babies are born prematurely each year. This is equivalent to 1 in 9 pregnancies in England and the numbers increase to 1 in every 7 pregnancies in London. In around 40% of cases, the cause of preterm birth are unknown. Current algorithms to predict preterm birth are limited in their ability to identify women at highest risk of delivering preterm and do not consider genetic, lifestyle and environmental circumstances within their prediction. With the rapid development of machine learning and deep learning, it is now possible to develop models which can consider a higher number of variables within their predictive algorithm, to formulate a patient specific prediction of risk. There is growing evidence that maternal exposure to air pollution during pregnancy is associated with an increased risk of preterm birth. Exposure to air pollution may be associated with poor placental function, pre-eclampsia, and poor fetal growth although there is limited data on these adverse pregnancy outcomes, all of which can lead to preterm birth. At present, many of the recent epidemiological studies in this area lack detailed and matching clinical data sets without gaps in electronic records.
This study aims to:
We aim to include data from pregnant women who delivered at UCLH from 2019 when EPIC was launched and until the end of 2023. There is no specified upper age range for this study. To improve inclusivity, we will aim to collect information from all women booking and delivering at UCLH to ensure minority ethnic groups and patients with social deprivation or with additional pregnancy complicating disorders are included within our dataset.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
We will work with stakeholders' policy groups e.g. RCOG, RCM, RCP and policy makers e.g. Department for Health and Social Care, Transport Emissions at the Greater London Authority or Mayor of London's office to disseminate our findings and develop public health messages. We aim to develop guidance on how pregnant women and their families can reduce their exposure to air pollution by highlighting for example travel routes with less pollution and wear face masks.
Machine learning model to predict the risk of preterm birth and adverse birth outcomes
We aim to develop a deep learning algorithm to predict the risk of preterm birth and other adverse pregnancy outcomes using data from electronic health records and a spatiotemporal model for ambient pollution levels within London. The model will consider personal, lifestyle and environmental factors alongside traditional risk factors to predict the gestation of pregnancy that delivery is most likely to occur. This can be classified as 'term', 'late preterm', 'moderate preterm', 'very preterm' and 'extreme preterm'.
Time frame: 36 months
Machine learning model to predict how air quality increases the risk of preterm birth and adverse birth outcomes
This model will also review the temporal sequence of events within a patient's medical history and current pregnancy, identifying significant interactions. Other adverse pregnancy outcomes such as birthweight, birthweight centile, pre-eclampsia, small for gestational age, fetal growth restriction will also be studied.
Time frame: 42 months
Plan to share: No — Data from the EPIC electronic health records database will be anonymized at UCLH to create a secondary dataset with anonymized identifier for patient identifier, postcode (area) and delivery date (month). Raw data screened. Patients excluded according to criteria.
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Oct 2029, 59 months after the start.
Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's planned 59 months is above that.
Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Queen Mary University of London →